Posters & Papers
Discover in this poster presented by Ryan Darling at WRIB 2026 on how a validated hybrid immunoaffinity LC–MS/MS method using a surrogate peptide and 2D chromatography enables selective, sub-ng/mL quantitation of a KLK1 analog in human plasma, overcoming LBA limitations caused by near-identical endogenous KLK1. If you have…
Blogs
CyTOF and spectral flow cytometry are widely used technologies for high-dimensional single cell profiling of immune cells. Both technologies enable multiparameter single-cell analysis, but they differ significantly in how data are generated, how quickly studies can be executed, and how flexible an assay can be tailored for a…
June 22
- June 25
KCAS Bio will be attending the BIO International Convention in San Diego, California from June 22 – 25, 2026. The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from around the world. This event is…
News
KCAS Bio is pleased to announce that Dr Mouhssin Oufir, General Manager of KCAS Bio Lyon, was recently featured on Paroles d’Entreprises, broadcast on BFM Business and hosted by Vincent Touraine. During the interview, he shared insights into how the group KCAS Bio supports pharmaceutical and…
May 12
- May 13
KCAS Bio will be attending Meet 2 Win in Bordeaux, on May 12-13, 2026. This event is a two-day partnering convention combining conferences, collaborative sessions, spotlight sessions, one-to-one prescheduled meetings as well as an exhibition area. Integrated Bioanalytical Support for Oncology Development KCAS Bio supports oncology and immuno-oncology programs…
May 11
- May 15
KCAS Bio is exhibiting at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), taking place May 11th-15th, 2026, in Boston, MA. This event serves as a global hub for scientific discovery and collaboration, bringing together leaders and innovators in the field of gene and…
May 11
- May 14
KCAS Bio will be exhibiting at the American Association of Pharmaceutical Scientists National Biotechnology Conference (AAPS NBC), taking place from May 11th to May 14th, 2026, in San Diego, California. Visit KCAS Bio at Booth #302 to engage with our experts, explore our cutting-edge bioanalysis solutions, and learn how…
Blogs
In nonclinical development, the transition from in vitro potential to in vivo reality is governed by a single, fundamental metric: dose formulation analysis. Dose formulation analysis in nonclinical studies serves as a critical control point, ensuring that dosing accuracy, consistency, and stability are maintained throughout the study lifecycle.
Podcasts
On this latest episode of The Weekly Bioanalysis podcast, Dom and John dive into one of the most pressing challenges in modern bioanalysis: how to break down silos and drive better project execution through continuity across teams. Drawing from real-world experience, they explore how the industry has evolved from…
Blogs
The world of medicine relies heavily on innovation, and Contract Research Organizations (CROs) are key players behind the scenes. But what exactly is a CRO, and why are these organizations so crucial to the development of new therapies and medical advancements? Let’s explore what CROs do and why they’re…
May 4
- May 5
KCAS Bio will be attending Swiss Biotech Day in Basel, on May 4-5, 2026. The Swiss Biotech Day is a global life sciences conference that brings together thousands of professionals from around the world to network, exchange ideas, and drive international collaboration across R&D, manufacturing, AI, and investment.
News
In modern bioanalytical research, data quality remains the defining metric of success. At the same time, study complexity continues to increase. KCAS Bio is advancing its global flow cytometry services with a focused strategy that integrates AI-enabled efficiencies, harmonized workflows, and high-parameter technologies. The goal…